Aromatase inhibitors in breast cancer survivors Dec. 06, 2012 Overview Show transcript Overview Sandhya Pruthi, director of the Breast Diagnostic Clinic at Mayo Clinic's campus in Rochester, Minnesota, discusses her article on managing aromatase inhibitors in breast cancer survivors. Share Doximity Facebook LinkedIn Twitter Print details Receive Mayo Clinic news in your inbox. Sign up VID-20439982 Medical Professionals Aromatase inhibitors in breast cancer survivors